Itonis, Inc. (ITNS)
Itonis, Inc.
22951 Mill Creek Drive
Suite A-1
Laguna Hills, CA 92653
United States
949-200-8887
https://www.itonisholdings.com
Sector(es): Healthcare
Industria: Medical Distribution
Empleados a tiempo completo: 3
Ejecutivos clave
| Nombre | Título | Pagar | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Mark H. Cheung | CEO, President & Director | N/D | N/D | N/D |
| Dr. Donald L. Jolly | CFO & Treasurer | N/D | N/D | N/D |
| Mr. Corey Washington | Chief Technology Officer | N/D | N/D | N/D |
| Dr. Charles B. Hensley Ph.D. | President of Itonis Pharmaceuticals | N/D | N/D | N/D |
Descripción
Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.
Gestión corporativa
La calificación ISS Governance QuickScore de Itonis, Inc. a partir del N/D es N/D. Las puntuaciones principales son Auditoría: N/D; Junta: N/D; Derechos del accionista: N/D; Compensación: N/D.
